Market cap
$6 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
37.49
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.4
-
Face value
--
-
Shares outstanding
33,261,500
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Holdco Nuvo Group D.G (NUVO)
| -96.7 | -88.9 | -88.9 | -- | -- | -- | -- |
|
BSE Sensex*
| -10.1 | -2.5 | 2.0 | -5.0 | 5.2 | 5.7 | 10.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Holdco Nuvo Group D.G (NUVO)
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that... provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité " Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Read more
-
CEO & Director
Mr. Robert Maurice Powell Jr.
-
Chief Financial Officer
Mr. Douglas L. Blankenship
-
Headquarters
Tel Aviv
-
Website
FAQs for Holdco Nuvo Group D.G (NUVO)
What is the current share price of Holdco Nuvo Group DG Ltd (NUVO) Today?
The share price of Holdco Nuvo Group DG Ltd (NUVO) is $0.00 (NYSE) and $0.00 (NASDAQ) as of 11-Aug-2025 09:30 EDT. Holdco Nuvo Group DG Ltd (NUVO) has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Holdco Nuvo Group DG Ltd (NUVO)?
Since, TTM earnings of Holdco Nuvo Group DG Ltd (NUVO) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-4.00 |
-1.99 |
2022 |
158.67 |
1.42 |
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
What is the 52 Week High and Low of Holdco Nuvo Group DG Ltd (NUVO)?
The 52-week high and low of Holdco Nuvo Group DG Ltd (NUVO) are Rs -- and Rs -- as of 04-Sep-2026.
What is the market cap of Holdco Nuvo Group DG Ltd (NUVO)?
Holdco Nuvo Group DG Ltd (NUVO) has a market capitalisation of $ 6 Mln as on 11-Aug-2025. As per SEBI classification, it is a Small Cap company.
Should I invest in Holdco Nuvo Group DG Ltd (NUVO)?
Before investing in Holdco Nuvo Group DG Ltd (NUVO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.